USA flag logo/image

An Official Website of the United States Government

DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES

Award Information

Agency:
Department of Health and Human Services
Branch:
N/A
Award ID:
54581
Program Year/Program:
2001 / STTR
Agency Tracking Number:
1R41GM061408-01A1
Solicitation Year:
N/A
Solicitation Topic Code:
N/A
Solicitation Number:
N/A
Small Business Information
MOLECULAR DESIGN INTERNATIONAL, INC.
111 South Highland Street MEMPHIS, TN 38111-
View profile »
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
 
Phase 1
Fiscal Year: 2001
Title: DEVELOPMENT OF MULTI-RECEPTOR LC STATIONARY PHASES
Agency: HHS
Contract: PHS2001-2
Award Amount: $100,000.00
 

Abstract:

DESCRIPTION: (Applicant's description) Combinatorial methods for the synthesis of new drug substances require high throughput techniques for evaluation of structure-activity relationships. Microliter plates with immobilized target receptors can rapidly reduce thousands of possibilities to hundreds of candidates. The next level of screening has proven to be more difficult and tedious. The goal of this project is the creation of an on-line screening approach to expedite secondary screening. The new technology involves immobilized bipolymer HPLC columns (IBCs)containing immobilized multiple receptors. Test compounds will be injected onto the IBC and chromatographed using standard HPLC techniques. The compounds will differentially adhere to the IBC according to their relative affinity for the immobilized receptors, i.e. compounds with little or no affinity to their relative affinity will wash through the IBC while those with moderate affinities will be displaced by ones with higher binding constants. The bipolymer-bound compounds will be sequentially displaced using a characterized ligand and the liberated compounds directed on-line into a mass spectrometer. Thus a large series of compounds can be rapidly screened for their relative affinities for the immobilized receptors with concurrent identification of molecular structures. The objective of this project is to develop prototypic IBCs using GABA, and nicotinic receptors. PROPOSED COMMERCIAL APPLICATION: The immobilized bipolymer columns (IBC's) developed in this project represent a new product for use in the pharmaceutical industry. A series of IBC's will be created for use in combinatorial screens and should find a substantial market as part of a high-throughput screen for new drug substances.

Principal Investigator:

Robert R. Clarke
2026873755
CLARKER@GEORGETOWN.EDU

Business Contact:


9015241010
PURCELL@MOLECULARDESIGN.COM
Small Business Information at Submission:

MOLECULAR DESIGN INTERNATIONAL
BOX 41777, 131 GAYOSO LN MEMPHIS, TN 38174 MEMPHIS, TN 38103

EIN/Tax ID: 621019562
DUNS: N/A
Number of Employees: N/A
Woman-Owned: No
Minority-Owned: No
HUBZone-Owned: No
Research Institution Information:
GEORGETOWN UNIVERSITY MEDICAL CENTER
GEORGETOWN UNIVERSITY MEDICAL CENTER
WASHINGTON, DC 20057
RI Type: Nonprofit college or university